Key result
A comprehensive review of malignant hyperthermia highlights its presentation, treatment, prevalence, and pathogenesis to help eliminate associated mortalities in orthopedic surgery.
This review provides a comprehensive overview of malignant hyperthermia to educate clinicians on its presentation, treatment, and prevention to eliminate associated mortalities.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to malignant hyperthermia in orthopedics; leaves open prospective validation of mortality reduction.
Most frequently associated with orthopedic surgery, malignant hyperthermia is a rare genetic condition linked to volatile anesthetics and succinylcholine. If not treated quickly with appropriate measures, death may result. To aid in the prevention of further fatalities, this review seeks to educate clinicians and staff on the presentation and treatment of this disease, as well as to provide a comprehensive overview by further addressing prevalence, similar conditions, pathogenesis and other aspects. Although the number of deaths due to malignant hyperthermia has greatly declined in the last several years, increased knowledge may eliminate associated mortalities, particularly in the orthopedic setting.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2018) conducted a review in Malignant hyperthermia. A comprehensive review of malignant hyperthermia highlights its presentation, treatment, prevalence, and pathogenesis to help eliminate associated mortalities in orthopedic surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: